Who funds eye and vision research?

We count 157 funded eye and vision projects, active between 2019 and 2034, from 6 funders. The most came from EU · ERC (46 projects), EU · MSCA (29 projects) and Wellcome (21 projects). The median award is $2.1M, across the 151 of 157 projects that list an amount.

Funded projects

157

Funders

6

Median award

$2.1M

Open calls now

0

Top funders of eye and vision research

Projects whose title or summary mentions eye and vision. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open eye and vision funding calls

No open call mentions eye and vision in our listings today. We add new calls twice a day; create a free account to get an alert when one opens.

Forecast: announced, not open yet

2 forecast calls on eye and vision. Funders publish forecasts before a call opens; you can't apply to these yet, and dates can change.

• ForecastRehabilitation Engineering Research Center on Technologies for People Who are Blind or have Low Vision
  Administration for Community Living$970,000 – $975,000Expected to open February 22, 2027
• ForecastR3PEATS Rigor Scholar Cohort Awards (K12)
  National Institutes of HealthNot specifiedExpected to open July 1, 2027

Funded eye and vision projects

A sample, latest start first, at most three per program.

• From Pigment To Pattern: Mechanisms Shaping Foveal Specialisation
  Wellcome · £2,037,998 · ends 2034
• Phase 3 trial to assess M72/AS01E-4 Mycobacterium tuberculosis (TB) vaccine
  Wellcome · £125,955,160 · ends 2033
• Clarifying the Optimal Application of SLT Therapy (COAST) Trial
  NIH · NEI · $3,334,327 · ends 2031
• The Hidden Cell Discovery Research Platform
  Wellcome · £9,558,000 · ends 2030
• Ketamine Add-On for Established Status Epilepticus Treatment Trial (KESETT)
  NIH · NINDS · $5,668,197 · ends 2030
• Telerehabilitation In The Home After Stroke: A Randomized, Controlled, Assessor-Blind Clinical Trial (The TR-2 Trial)
  NIH · NINDS · $4,453,239 · ends 2030
• Harnessing the glucose lowering actions of a-melanocyte stimulatory hormone as a potential new adjunctive therapy for people with type 2 diabetes
  UKRI · MRC · £1,426,333 · ends 2030
• Novel area-modulation perimetry for identifying changes in visual field sensitivity over time: The REVAMP+ Study
  UKRI · MRC · £2,179,783 · ends 2030
• Collaborative Research: VINES: Track 2: VICEROY: Vehicular Integrated Sensing and Communications for Enhanced Road Safety
  NSF · TIP · $3,747,903 · ends 2029
• Physics-Composed Generative Policies: Embedding Vision-Native Gaussian Contact Physics for Reliable and Transferable Autonomy
  NSF · ENG · $350,980 · ends 2029

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “retina or retinal or blindness or glaucoma”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.